Basile Joyce E, Donnenfeld Alan E
Genzyme Genetics, 833 Chestnut Street, Suite 1250, Philadelphia, PA 19107, USA.
J Reprod Med. 2011 Sep-Oct;56(9-10):415-20.
To determine the percentage of potential ovum donors who have an increased risk for fetal harm.
Couples using an ovum donor to conceive a pregnancy are expecting to select someone who poses a low genetic risk to their offspring. Currently, most genetic carrier screening of these donors is performed at the discretion of the fertility center. This investigation involves a review of family history and genetic carrier test results of oocyte donor candidates.
A total of 210 (22.1%) of 950 potential oocyte donors had at least one fetal risk factor based on family history. Of 244 prospective donors who had genetic testing, 15 (6.1%) were found to be carriers of hereditary diseases that could pose an increased risk to a fetus.
A genetic assessment is a critical step in the evaluation of prospective oocyte donors, because almost one quarter of donors had a family history of a disease that could pose an increased fetal risk. Disclosure of ovum donor carrier status and, when applicable, testing of partners is required before accepting a potential ovum donor in an infertility program.
确定具有胎儿伤害风险增加的潜在卵子捐赠者的比例。
使用卵子捐赠者来受孕的夫妇期望选择对其后代遗传风险较低的人。目前,这些捐赠者的大多数基因携带者筛查由生育中心自行决定。本研究回顾了卵子捐赠候选者的家族史和基因携带者检测结果。
在950名潜在卵子捐赠者中,共有210名(22.1%)基于家族史至少有一个胎儿风险因素。在244名进行基因检测的准捐赠者中,有15名(6.1%)被发现是遗传性疾病的携带者,这可能会增加胎儿的风险。
基因评估是评估准卵子捐赠者的关键步骤,因为近四分之一的捐赠者有家族病史,可能会增加胎儿风险。在不孕不育项目中接受潜在卵子捐赠者之前,需要披露卵子捐赠者的携带者状态,并在适用时对伴侣进行检测。